CDTX vs COP
Cidara Therapeutics Inc (CDTX) versus ConocoPhillips (COP) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
ConocoPhillips (COP) is a oil & gas e&p company listed on NYSE. It is led by Ryan Lance.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported COP revenue for 2025-12-31 was $58.94B. Net income was $7.99B. Revenue was up 7.7% from 2024-12-31 to 2025-12-31. COP currently screens at market cap $135.49B and trailing P/E 18.8.
CDTX currently screens at market cap $6.96B. COP currently screens at market cap $135.49B and trailing P/E 18.8.
Not investment advice. Open the CDTX and COP stock pages for the full models.
Not investment advice.